U S PHYSICAL THERAPY INC /NV
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M |
| Gross profit | $149.7M | $123.9M | $121.5M | $112.0M | $117.2M |
| Selling, general & administrative | $69.3M | $58.3M | $52.0M | $46.1M | $46.5M |
| Operating income | $86.7M | $63.0M | $50.5M | $56.8M | $70.6M |
| Pretax income | $77.8M | $60.2M | $49.4M | $55.6M | $73.2M |
| Income tax expense | $19.8M | $14.6M | $12.2M | $12.2M | $15.3M |
| Net income | $39.6M | $31.4M | $28.2M | $32.2M | $40.8M |
| Balance Sheet | |||||
| Cash and equivalents | $35.6M | $41.4M | $152.8M | $31.6M | $28.6M |
| Current assets | $140.0M | $137.6M | $233.4M | $111.3M | $95.2M |
| Total assets | $1.2B | $1.2B | $997.2M | $858.2M | $749.4M |
| Current liabilities | $139.0M | $116.3M | $102.2M | $85.5M | $83.5M |
| Total liabilities | $433.8M | $408.4M | $345.0M | $373.6M | $297.0M |
| Total debt | $162.5M | $153.5M | $146.7M | $183.7M | $118.4M |
| Stockholders' equity | $476.4M | $488.9M | $476.2M | $315.8M | $295.6M |
| Cash Flow Statement | |||||
| Cash from operations | $75.1M | $74.9M | $82.0M | $58.5M | $76.4M |
| Depreciation and amortization | $22.4M | $18.7M | $15.7M | $14.7M | $11.6M |
| Stock-based compensation | $8.3M | $7.8M | $7.2M | $7.3M | $7.9M |
| Capital expenditure | $14.1M | $9.2M | $9.3M | $8.2M | $8.2M |
| Free cash flow | $61.0M | $65.8M | $72.7M | $50.3M | $68.2M |
| Dividends paid | $27.4M | $26.5M | $24.1M | $21.3M | $18.8M |
| Share repurchases | $5.6M | $0 | $0 | — | — |
| Impairments | $0 | $0 | $15.8M | $9.1M | $0 |
Shares outstanding 15.2M · Free float 97.6%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.